New §232 tariffs target pharmaceutical imports: 100% on patented drugs from manufacturers not offering most-favored-nation pricing, with tiered rates for companies demonstrating onshoring commitments. Effective date is July 31, 2026.

Congress

Find lawmakers and committees

Daily Signals alert

Get relevant trade-policy alerts in Daily Trade Signals.

Subscription scopeDaily Trade SignalsThe daily email, with this source context saved for matching.Only §232Filter future fragments toward this policy instrument.This HS code or caseFollow changes linked to HS 30.

Subscribes you to Daily Trade Signals and stores this source page, selected scope, and a timestamp for alert matching. Unsubscribe anytime. See our privacy policy.

Review Snapshot

Scope: HS 30 / ALL / §232 / pharmaceuticals
Question: Does this source change alter exposure, timing, or review priority for HS 30 / ALL / §232 / pharmaceuticals?
Next move: Check HS 30 in Tariffs, then save the scope if this question repeats.

What Changed

Event type: Proclamation Issued
Restriction: Import · Tariff
Target goods: pharmaceuticals
Target countries: ALL

Legal / Policy Context

Legal basis

Section 232

Policy instruments

§232

Practical Takeaways

Check the tagged HS codes in tariff context before treating this as a general market signal.
Use Paths to see adjacent source records, countries, and instruments before escalating this as a standalone change.

Source Trail

The White HousePrimary briefing source

Open source